Health News


Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
07/21/17PBYIPB272 (Neratinib) (NDA)FDA decision on PB272 for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer
07/19/17AMGNRomosozumab (BLA)FDA decision on Romosozumab for the treatment of osteoporosis in postmenopausal women at increased risk of fracture
07/19/17OCULDEXTENZA (NDA resubmission)FDA decision on DEXTENZA for treatment of ocular pain occurring after ophthalmic surgery
06/30/17RDUSAbaloparatide-SC (NDA)FDA decision on Abaloparatide–SC for postmenopausal women with osteoporosis
06/30/17ARRYBinimetinib (NDA)FDA decision on Binimetinib for patients with NRAS-mutant melanoma.
06/30/17TSRONiraparib (NDA)FDA decision on Niraparib a treatment for patients with recurrent epithelial ovarian for treatment of fallopian tube, or primary peritoneal cancer
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data